{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:13:14Z","timestamp":1789913594333,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.vaccine.2008.07.029","type":"journal-article","created":{"date-parts":[[2008,8,4]],"date-time":"2008-08-04T13:45:30Z","timestamp":1217857530000},"page":"4991-4997","source":"Crossref","is-referenced-by-count":56,"title":["Immunogenicity assay of the Leishmune\u00ae vaccine against canine visceral leishmaniasis in Brazil"],"prefix":"10.1016","volume":"26","author":[{"given":"G.P.","family":"Borja-Cabrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.N.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.S.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.E.","family":"Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Menz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Morgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.S.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.M.","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.B.","family":"Palatnik-de-Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.07.029_bib2","unstructured":"World Health Organization-TDR. The TDR fifteenth programme report. Research Progress 1999\u20132000. New and Improved Tools 2003. www.who.int\/tdr\/research\/progress 9900\/tools\/vdr.html."},{"key":"10.1016\/j.vaccine.2008.07.029_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4269\/ajtmh.1995.52.287","article-title":"Control of zoonotic visceral leishmaniasis. Is it time to change strategies?","volume":"52","author":"Tesh","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.07.029_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4269\/ajtmh.1996.55.125","article-title":"The logic of visceral leishmaniasis control","volume":"55","author":"Dye","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.07.029_bib5","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(00)03128-7","article-title":"Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, doubled-blind, BCG-controlled trial in Sudan","volume":"356","author":"Khalil","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.07.029_bib6","first-page":"4097","article-title":"Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district","volume":"22","author":"Mohebali","year":"2004","journal-title":"I R Iran Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib7","first-page":"116","article-title":"Phase III randomized double blind clinical trial on the efficacy of a vaccine against canine visceral leishmaniasis in urban area of Montes Claros, MG, Brazil","volume":"91","author":"Genaro","year":"1996","journal-title":"Mem Ins Osw Cruz"},{"key":"10.1016\/j.vaccine.2008.07.029_bib8","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.vaccine.2004.11.061","article-title":"Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes","volume":"23","author":"Lemesre","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1051\/vetres:2005033","article-title":"Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis","volume":"36","author":"Fujiwara","year":"2005","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2008.07.029_bib10","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1016\/j.vaccine.2007.05.010","article-title":"Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis","volume":"25","author":"Moreno","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib11","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1016\/j.vaccine.2005.07.001","article-title":"Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals","volume":"23","author":"Gradoni","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib12","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1016\/j.vaccine.2005.02.009","article-title":"Protective vaccination against canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and type II of L. infantum","volume":"23","author":"Rafati","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib13","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1016\/j.vaccine.2007.08.023","article-title":"Vaccination with plasmid DNA encoding KMP11, TRYP, LACK, and GP63 does not protect dogs against Leishmania infantum experimental challenge","volume":"25","author":"Rodr\u00edguez-Cort\u00e9s","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib14","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(03)00032-X","article-title":"Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA vaccine and vaccinia recombinant vectors expressing LACK","volume":"21","author":"Ramiro","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib15","series-title":"Vaccine congress on nucleoside hydrolase DNA vaccine against visceral leishmaniasis. vol. 1. Celebrating 25 years of publication","first-page":"pp. 167","author":"Borja Cabrera","year":"2007"},{"key":"10.1016\/j.vaccine.2008.07.029_bib16","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2008.01.023","article-title":"Vaccines for leishmaniasis in the fore coming 25 years. Review","volume":"26","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib17","first-page":"1068","article-title":"A Phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (S\u00e3o Gon\u00e7alo do Amarante, RN)","volume":"19","author":"da Silva","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib18","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/S0264-410X(02)00294-3","article-title":"Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S\u00e3o Gon\u00e7alo do Amarante)","volume":"20","author":"Borja-Cabrera","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib19","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/j.vaccine.2007.02.083","article-title":"Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial","volume":"25","author":"Lemesre","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib20","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/IAI.57.3.754-763.1989","article-title":"Inhibition of Leishmania donovani promastigote internalization into murine macrophages by chemically defined parasite glycoconjugate","volume":"57","author":"Palatnik","year":"1989","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.07.029_bib21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0035-9203(95)90022-5","article-title":"Leishmania donovani: titration of antibodies to the Fucose Mannose Ligand as an aid in diagnosis and prognosis of Visceral Leishmaniasis","volume":"89","author":"Palatnik de Sousa","year":"1995","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.07.029_bib22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1999.61.296","article-title":"The FML-ELISA assay in diagnosis and prognosis of canine visceral leishmaniasis","volume":"6","author":"Borja Cabrera","year":"1999","journal-title":"Am J Trop Med"},{"key":"10.1016\/j.vaccine.2008.07.029_bib23","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1016\/j.vaccine.2005.05.011","article-title":"Leishmune\u00ae vaccine blocks the transmission of canine visceral leishmaniasis. Absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs","volume":"23","author":"Nogueira","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib24","unstructured":"Borja-Cabrera GP. PhD Thesis. An\u00e1lise do potencial diagn\u00f3stico, progn\u00f3stico e imunoprotetor do ant\u00edgeno FML (Ligante de Fucose Manose) de Leishmania (L.) donovani, no calazar canino experimental e de \u00e1rea end\u00eamica. Universidade Federal Fluminense; 2000. pp. 81\u201398."},{"key":"10.1016\/j.vaccine.2008.07.029_bib25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0264-410X(02)00444-9","article-title":"Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis","volume":"21","author":"Santos","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib26","first-page":"290","article-title":"The FML vaccine (fucose\u2013manosse ligand) protects hamsters from experimental kala-azar","volume":"46","author":"Palatnik de Sousa","year":"1994","journal-title":"Ci\u00eancia e Cultura (J Braz Assoc Adv Sci)"},{"key":"10.1016\/j.vaccine.2008.07.029_bib27","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1016\/S0264-410X(03)00527-9","article-title":"Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine","volume":"21","author":"Santos","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib28","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.vaccine.2003.11.039","article-title":"Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine","volume":"22","author":"Borja-Cabrera","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib29","unstructured":"UNDP\/World Bank\/WHO Special Programme for Research and Training in Tropical Diseases (TDR). Guidelines for the evaluation of Plasmodium falciparum vaccines in populations exposed to natural infections. TDR\/MAL\/VAC\/97. World Health Organization, Geneva, Switzerland."},{"key":"10.1016\/j.vaccine.2008.07.029_bib30","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.vaccine.2005.11.061","article-title":"The FML-vaccine (Leishmune\u00ae) against canine visceral leishmaniasis: a transmission blocking vaccine","volume":"24","author":"Saraiva","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib31","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1016\/j.vaccine.2007.06.005","article-title":"Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune\u00ae vaccine","volume":"25","author":"Santos","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib32","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.vaccine.2006.11.057","article-title":"Safety trial using the Leishmune\u00ae vaccine against canine visceral leishmaniasis in Brazil","volume":"25","author":"Parra","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib33","unstructured":"Minist\u00e9rio da Sa\u00fade-SINAN-Secretaria de Vigil\u00e2ncia em Sa\u00fade. Manual de Vigil\u00e2ncia e Controle da Leishmaniose Visceral. Editora Minist\u00e9rio da Sa\u00fade. Bras\u00edlia-DF; 2003. 120 pp."},{"key":"10.1016\/j.vaccine.2008.07.029_bib34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1590\/S0001-37652004000300012","article-title":"Improving methods for epidemiological control of canine visceral leishmaniasis based on a mathematical model. Impact on the incidence of the canine and human disease","volume":"76","author":"Palatnik-de-Sousa","year":"2004","journal-title":"Ann Braz Acad Sci"},{"key":"10.1016\/j.vaccine.2008.07.029_bib35","unstructured":"Prefeitura de Belo Horizonte\/Portal Internet. Sa\u00fade, leishmaniose. http:\/\/portal1.pbh.gov.br."},{"key":"10.1016\/j.vaccine.2008.07.029_bib36","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1016\/j.vaccine.2006.02.034","article-title":"Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis","volume":"24","author":"Oliveira-Freitas","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib37","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S1359-6446(03)02864-2","article-title":"Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity","volume":"8","author":"Marciani","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.vaccine.2008.07.029_bib38","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.vaccine.2004.08.022","article-title":"Pulcherrima saponin, from the leaves of Calliandra pulcherrima, as adjuvant for visceral leishmaniasis","volume":"23","author":"Silva","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib39","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1590\/S0001-37652003000400005","article-title":"Importance of CD8 T cell-mediated immune response during intracellular parasitic infections and its implications for the development of effective vaccines","volume":"75","author":"Rodrigues","year":"2003","journal-title":"Ann Acad Bras Cienc"},{"key":"10.1016\/j.vaccine.2008.07.029_bib40","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.4049\/jimmunol.168.8.3992","article-title":"CD8+ T cells are required for primary immunity in C57BL\/6 mice following low-dose, intradermal challenge with Leishmania major","volume":"168","author":"Belkaid","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.07.029_bib41","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0264-410X(98)00338-7","article-title":"Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis","volume":"17","author":"De Luca","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib42","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1128\/IAI.69.5.3232-3239.2001","article-title":"Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis","volume":"69","author":"Bottrel","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.07.029_bib43","doi-asserted-by":"crossref","first-page":"7453","DOI":"10.1128\/IAI.69.12.7453-7460.2001","article-title":"Differences in gamma interferon production in vitro predict the pace of the in vivo response to Leishmania amazonensis in healthy volunteers","volume":"69","author":"Pompeu","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.07.029_bib44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2249.2006.03206.x","article-title":"Phenotypic features of circulating leucocytes as immunological markers for clinical status and bone marrow parasite density in dogs naturally infected by Leishmania chagasi","volume":"146","author":"Reis","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2008.07.029_bib45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/rvsc.2000.0419","article-title":"Canine leishmaniasis transmission: higher infectivity amongst naturally infected dogs to sand flies is associated with lower proportions of T helper cells","volume":"69","author":"Guarga","year":"2000","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2008.07.029_bib46","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.vaccine.2008.02.044","article-title":"Despite Leishvaccine and Leishmune trigger distinct immune profiles, their ability to activate phagocytes and CD8+ T-cells support their high-quality immunogenic potential against canine visceral leishmaniasis","volume":"26","author":"Ara\u00fajo","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib47","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1016\/j.vaccine.2007.08.009","article-title":"Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs","volume":"25","author":"Giunchetti","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib48","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0165-2427(96)05768-6","article-title":"Lymphocyte subset abnormalities in canine leishmaniasis","volume":"56","author":"Bourdoiseau","year":"1997","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2008.07.029_bib49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0165-2427(99)00096-3","article-title":"The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy","volume":"71","author":"Moreno","year":"1999","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2008.07.029_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-2427(02)00128-9","article-title":"Evaluation of a specific immunochemotherapy for the treatment of canine visceral leishmaniasis","volume":"88","author":"Guarga","year":"2002","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2008.07.029_bib51","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/030098588402100113","article-title":"Visceral leishmaniasis in the German shepherd dog. I. Infection, clinical disease, and clinical pathology","volume":"21","author":"Keenan","year":"1984","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2008.07.029_bib52","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/S0264-410X(03)00046-X","article-title":"IgG1\/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniasis","volume":"21","author":"Mendes","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.029_bib53","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-3024.1995.tb00914.x","article-title":"Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites","volume":"17","author":"Deplazes","year":"1995","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2008.07.029_bib54","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0165-2427(98)00213-X","article-title":"Analysis of the humoral response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis","volume":"67","author":"Nieto","year":"1999","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2008.07.029_bib55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0304-4017(00)00446-5","article-title":"Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment","volume":"96","author":"Solano-Gallego","year":"2001","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2008.07.029_bib56","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1086\/344312","article-title":"Infectiousness in a Cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission","volume":"186","author":"Courtenay","year":"2002","journal-title":"J Inf Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08009730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08009730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T12:11:13Z","timestamp":1588853473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08009730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":55,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0264410X08009730"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.07.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}